🔗 Share this article TikTok Influencers Driving Unofficial Trade for Unapproved Weight-Loss Medication An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations. Investigational Drug Gaining Traction Via Social Media The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles privately for supplier links, while also receiving discount codes. Active Commerce on Messaging Platforms Separately, a robust market exists on messaging services, where communities with thousands of participants share comparison images, injection guides and claims of next-day UK delivery. Vendors promote the substance there before directing buyers to other platforms for transactions. Understanding The Experimental Drug Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic. Medical Professionals Voice Worries However, doctors and pharmacists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in individuals injecting products of unknown origin. Several experts stated the demand for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro. Regulatory Position and Implementation Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012. Some content creators try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment. Service Reaction and Content Removal According to TikTok, the service has taken down problematic content and banned associated keywords and search suggestions. The organization said it was dedicated to keeping the service secure and allocating resources in enhancing enforcement strategies. Online Marketplace Operations Investigations also discovered groups with up to nine thousand participants marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with numerous of members, filled with photos of weight loss, positive reviews and step-by-step guides for mixing or administering at home. Within moments of entering one community, a seller posted contact information, where most transactions occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about body mass, health issues or past usage. Item Details and Costs Inside these groups, messages show black plastic parcels with Royal Mail labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.” Customers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how long a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”. Service Moderation and Security Measures A representative for Telegram said it regularly moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”. Medical Expert Cautions “Individuals are injecting materials they can’t verify. Although the research behind retatrutide is valid, these digital versions may not include what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U. A medical professional of Asda Online Doctor connected the increase in interest to recent cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said. Her team has previously seen individuals harmed by personal administration from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.” Producer Statement A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company investigational product not yet authorized … may expose users to potentially serious health risks”.